DETAILED NOTES ON SITUS JUDI MBL77

mutations specified the fact that, as described below, CLL therapy relies on the presence or absence of such mutations. The current consensus is always that, in addition to clonal mutations, subclonal mutations having a variant allelic frequency starting from five to 10% (and so below the threshold of detection by regular molecular techniques) coul